Digital therapeutics (DTx) firm Sidekick Health today announced a raise of $55 million (€52M) in Series B funding.
The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor that will be revealed at a later stage.
WHAT IT DOES
Sidekick develops and...
